Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences (HSCS) has disclosed Gross Margin for 5 consecutive years, with 58.33% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin changed N/A year-over-year to 58.33%, compared with a TTM value of 3.56% through Oct 2025, changed N/A, and an annual FY2025 reading of 56.78%, down 1052.0% over the prior year.
  • Gross Margin was 58.33% for Q4 2025 at HeartSciences, down from 60.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 69.15% in Q2 2022 and bottomed at 23.09% in Q3 2021.
  • Average Gross Margin over 5 years is 56.31%, with a median of 61.03% recorded in 2023.
  • The sharpest move saw Gross Margin skyrocketed 1329bps in 2022, then crashed -781bps in 2023.
  • Year by year, Gross Margin stood at 23.09% in 2021, then soared by 58bps to 36.38% in 2022, then surged by 68bps to 61.03% in 2023, then grew by 13bps to 68.97% in 2024, then decreased by -15bps to 58.33% in 2025.
  • Business Quant data shows Gross Margin for HSCS at 58.33% in Q4 2025, 60.0% in Q3 2025, and 68.97% in Q1 2024.